Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Retained Earnings (2019 - 2025)

Historic Retained Earnings for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to -$1.5 billion.

  • CureVac's Retained Earnings rose 355.21% to -$1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.5 billion, marking a year-over-year increase of 355.21%. This contributed to the annual value of -$1.5 billion for FY2024, which is 1096.87% up from last year.
  • Per CureVac's latest filing, its Retained Earnings stood at -$1.5 billion for Q3 2025, which was up 355.21% from -$1.7 billion recorded in Q2 2025.
  • In the past 5 years, CureVac's Retained Earnings ranged from a high of -$1.1 billion in Q2 2021 and a low of -$1.8 billion during Q2 2024
  • For the 5-year period, CureVac's Retained Earnings averaged around -$1.5 billion, with its median value being -$1.5 billion (2023).
  • Its Retained Earnings has fluctuated over the past 5 years, first plummeted by 18135040.99% in 2021, then soared by 1386.21% in 2025.
  • Over the past 5 years, CureVac's Retained Earnings (Quarter) stood at -$1.2 billion in 2021, then decreased by 10.2% to -$1.3 billion in 2022, then dropped by 26.47% to -$1.7 billion in 2023, then increased by 10.97% to -$1.5 billion in 2024, then rose by 3.19% to -$1.5 billion in 2025.
  • Its last three reported values are -$1.5 billion in Q3 2025, -$1.7 billion for Q2 2025, and -$1.5 billion during Q1 2025.